These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34038188)

  • 1. Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells.
    Yin W; Xu J; Mao Y
    Biochem Cell Biol; 2021 Jun; 99(3):322-329. PubMed ID: 34038188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chloroquine enhances cisplatin-induced apoptosis of nasopharyngeal carcinoma cells by inhibiting autophagy via upregulating miR129].
    Zhang H; Yu Y; Cai W; Lu H; He R; Zhang R; Pei F; Wang X; Fang Y; Wei F
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):361-369. PubMed ID: 32376584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
    PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
    He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
    FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIX-01294-enhanced chemosensitivity in nasopharyngeal carcinoma depends on autophagy-induced pyroptosis.
    Li Q; Wang M; Zhang Y; Wang L; Yu W; Bao X; Zhang B; Xiang Y; Deng A
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1131-1139. PubMed ID: 33085742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells
    Wang H; Li W; Tan G
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):357-363. PubMed ID: 31068307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
    Sun XJ; Zhang P; Li HH; Jiang ZW; Jiang CC; Liu H
    Asian Pac J Cancer Prev; 2014; 15(9):4019-23. PubMed ID: 24935589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
    Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY
    Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
    Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z
    Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
    Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S
    Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Huang J; Li HB; Yu S; Yuan F; Lou ZP
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4793-4802. PubMed ID: 32432742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
    Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
    Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined application of cisplatin and celecoxib inhibits the proliferation and promotes apoptosis of nasopharyngeal carcinoma cells resistant to cisplatin].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):203-6, 211. PubMed ID: 25652863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.